Document sans nom

I - OUTCOMES FOR CLINICAL TRIALS IN ALZHEIMER’S DISEASE
········································································································
· Editorial: Outcomes For Alzheimer’s Trials, B. Vellas (France) Full text

· Clinical Relevance on Alzheimer’s Disease Endpoints, C. Sampaio (Portugal) Full text

· Outcomes for Disease Modifying Trials, G. Wilcock (United-Kingdom) Full text

· Outcome for Secondary Preventive Trials (in Mild Cognitive Impairment), E. Salmon (Belgium) Full text

· Measuring Cognitive Change in Alzheimer’s Disease Clinical Drug Trials, J.E. Harrison (United-Kingdom) Full text

II - ALZHEIMER’S DISEASE AND PREVENTION
········································································································
· Prevention of Alzheimer’s Disease, M. Zavaloni Scalco, R. van Reekum (Canada) Full text

· Exercise Reduces Risk of Dementia and Alzheimer’s Disease, E.B. Larson, L. Wang (USA) Full text

· The Effect of Social Engagement on Incident Dementia: the Honolulu-Asia Aging Study, J.S. Saczynski,
L.A. Pfeifer, K. Masaki, E.S.C. Korf, D. Laurin, L. White, L.J. Launer (USA, The Netherlands) Full text

· Fruit and Vegetable Intake and Cognitive Decline, H. Kang, F. Grodstein (USA) Full text

· Leisure Activities And The Risk of Dementia In The Elderly, A. Sanders, J. Verghese (USA) Full text

· Treating Vascular Risk Factors and Preventing Alzheimer’s, K. Alagiakrishnan (Canada) Full text

· Environmental Experience and Dementia, T.L. Briones (USA) Full text

· Increased Risk of Dementia in Diabetes Mellitus, G.J. Biessels, P. Scheltens (The Netherlands) Full text

· Early-Life Risk Factors for Alzheimer’s Disease, J.A. Mortimer, A.R. Borenstein (USA) Full text

III - NUTRITION COGNITIVE DECLINE AND ALZHEIMER
········································································································
· Oxidative Stress in Alzheimer Patients in Different Stages of the Disease, P. Zafrilla, J. Mulero, J.M. Xandri, E. Santo, G. Caravaca, J.M. Morillas (Spain) Full text

· Serum Copper in Alzheimer, R. Squitti, P.M. Rossini (Italy) Full text

· Dietary Fatty Acids and Prevention of Mild Cognitive Impairment and Alzheimer’s Disease, V. Solfrizzi,
C. Capurso, A. d’Introno, A.M. Colacicco, A. Del Parigi, G. Gagliardi, M. Chirico, G. Breglia,
A. Capurso, F. Panza (Italy) Full text

· Mediterranean Diet and Alzheimer’s Disease, N. Scarmeas, R. Mayeux, Y. Stern, J.A. Luchsinger (USA) Full text

IV – VASCULAR DISEASE AND DEMENTIA
········································································································
· Dementia and Cerebrovascular Disease, D.S. Knopman (USA) Full text

· How Useful are the MMSE and IQCODE in Diagnosing Cognitive Impairment and Dementia in Stroke Patients? J.M. Stapleton, A.G. Thrift, M.M. Saling, V.K. Srikanth (Australia) Full text

· Clinical Implications of Changes in Blood Pressure with Dementia, D.B. Petitti, V.C. Crooks, J. Galen Buckwalter, V. Chiu (USA) Full text

V – MCI AND COGNITIVE DECLINE
········································································································
· Predicting Conversion to Dementia from Amnestic Mild Cognitive Impairment using Neuropsychological Tests, K.L. Netson, H.R. Griffith, D.C. Marson (USA) Full text

· Assessing Memory Impairment in Early Alzheimer’s Disease: The DMS48, E.J. Barbeau, E. Guedj, O. Felician, M. Didic, J.P. Ranjeva, M. Poncet, M. Ceccaldi (France) Full text

· Hypertension as a Risk Factor for Transitions from Normal to Dementia or Mild Cognitive Impairment,
R.J. Kryscio, F.A. Schmitt, M.S. Mendiondo, W.R. Markesbery (USA) Full text

Daily Stressors and Memory Failures, S.D. Neupert (USA) Full text

· Post-operative Delirium Predicts Cognitive Deterioration in Non Demented Elderly Patients, O.V. Forlenza,
P. Wacker, P.V. Nunes, H.E. Cabrita (Brazil) Full text

VI - ALZHEIMER’S DISEASE: CLINICAL PRACTICE
········································································································
· Alzheimer’s Disease: Implications for Primary Care, D.P. Chapman, S.M. Williams, R.F. Anda, M.J. Moore (USA) Full text

· The Capacity to Vote of Persons with Alzheimer’s Disease, P.S. Appelbaum, R.J. Bonnie, J.H. Karlawish (USA) Full text

· Assessing the Quality of Life among Nursing Home Residents: Implications for Alzheimer’s Disease, R.L. Kane, R.A. Kane, H. Degenholtz (USA) Full text

· Hallucinations, Delusions and Alzheimer’s Disease Outcomes, N. Scarmeas, Y. Stern (USA) Full text

· Impact on Quality of Life of Faecal Incontinence on Older Adults Living at Home, A. Akpan, M.A. Gosney,
J. Barrett (Royaume-Uni) Full text

· Clinical and Pathological Characterisation of Progressive Aphasia, J.A. Knibb, J.H. Xuereb, K. Patterson,
J.R. Hodges (United-Kingdom) Full text

VII – THERAPEUTIC ADVANCES
········································································································
· Novel Immunogens for Amyloid-beta Immunotherapy, C.A. Lemere, M. Maier, Y. Peng, L. Jiang,
T.J. Seabrook (USA, Switzerland) Full text

· Therapeutic Developments in Alzheimer’s Disease, E.R.L.C. Vardy, N.M. Hooper (United-Kingdom) Full text

· Effects of γ-secretase Inhibitors in Alzheimer: a 2007 Update, E.R. Siemers, R.C. Mohs, P.C. May, D. Ness, R.A. Dean (USA) Full text

· Immunization Therapy in Alzheimer's Disease, F. Mor (Israël) Full text

· A High-Intensity Functional Exercise Program is Applicable for Older People with Cognitive Impairment ,
E. Rosendahl, H. Littbrand, N. Lindelöf, L. Lundin-Olsson, Y. Gustafson, L. Nyberg (Sweden) Full text

· Exercise, Cognition and Alzheimer’s Disease: More is not Necessarily Better, L. Eggermont, D. Swaab,
P. Luiten, E. Scherder (The Netherlands) Full text

· Psychotherapy in Alzheimer's Disease, A. Kaimal, A. Burns (United-Kingdom) Full text

· The Need for a Disease-modifying Treatment for Alzheimer’s Disease: Could Tramiprosate Be the Answer?
B. Vellas, D. Delorme, A. Herrera-Gayol, D. Garceau (France, Canada) Full text